Skip to main content
OpenTrials
Completed

NCT Number: NCT07184099

Phloroglucinol Effectiveness on Shortening the Duration of Active Phase of Labor

This study was planned to fill the gaps regarding the effectiveness of phloroglucinol on the duration of active phase of labor.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Labor

Age range

18 year–35 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Combined Military Hospital

Attock, Punjab Province, 43100, Pakistan

About this study

In today's era, the focus has shifted from a "wait and watch" policy to "active intervention sooner than later" to enhance better labor outcomes. Using an ideal antispasmodic drug would help achieve a rapid and prolonged effect on cervical dilation, with no adverse impact on uterine contractions or causing uterine inertia. If the current study finds phloroglucinol effective in shortening the duration of the active phase of labor, it would help achieve better patient outcomes.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pregnant women aged between 18-35 years
  • Period of gestation above 37 weeks.

Exclusion criteria

  • Women with cephalopelvic disproportion
  • Double scare uterus
  • Fetal distress
  • Life threatening bleeding
  • Eclampsia
  • History of heart disease
  • Known allergy to phloroglucinol

Treatment and study plan

Phloroglucinol

Drug

Phloroglucinol was administered as intravenous stat infusion with Ringer Lactate infusion.

Primary outcomes

  1. Duration of labor

    Time frame: 4 hours

    The duration of labor was measured from the time of diagnosis of labor until full dilatation of cervix.

Sponsors and collaborators

Lead sponsor

Muhammad Aamir Latif

Other

Registry information

Official study title

Effect of Phloroglucinol on Shortening the Duration of Active Phase of Labor

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Sep 19, 2025
Registry last updated
Sep 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.